Koyfin Home > Directory > Health Care > Boston Scientific Corp > Long-term Debt / Equity

Boston Scientific Corp Long-term Debt / Equity Chart (BSX)

Boston Scientific Corp annual/quarterly Long-term Debt / Equity from 2010 to 2020.
  • Boston Scientific Corp Long-term Debt / Equity for the quarter ending September 09, 2020 was $62m a -3.81% decrease of -2m year over year
  • Boston Scientific Corp Long-term Debt / Equity for the last 12 months ending September 09, 2020 was $62m a -3.81% decrease of -2m year over year
  • Boston Scientific Corp Annual Long-term Debt / Equity for 2019 was $64m a 13.87% increase of 9m from 2018
  • Boston Scientific Corp Annual Long-term Debt / Equity for 2018 was $55m a 1.15% increase of 1m from 2017
  • Boston Scientific Corp Annual Long-term Debt / Equity for 2017 was $54m a -47.96% decrease of -26m from 2016
Other Ratios Metrics:
  • Boston Scientific Corp Total Debt / Capital for the quarter ending December 12, 2018 was $44m a -1.42% decrease of -1m year over year
  • Boston Scientific Corp Other Liabilities for the quarter ending September 09, 2018 was $2,202m a -16.30% decrease of -359m year over year
  • Boston Scientific Corp Total Debt / Equity for the quarter ending December 12, 2018 was $80m a -2.59% decrease of -2m year over year
View Chart On Koyfin

Quarterly BSX Long-term Debt / Equity Data

09/2020$62m
06/2020$61m
03/2020$70m
12/2019$64m
09/2019$101m
06/2019$83m
03/2019$84m
12/2018$55m
09/2018$58m
06/2018$62m

Annual BSX Long-term Debt / Equity Data

2019$64m
2018$55m
2017$54m
2016$80m
2015$90m
2014$59m
2013$65m
2012$62m
2011$37m
2010$44m